Skip to main content

Hand, Foot and Mouth Disease (HFMD) and Onychomadesis



 

Introduction

Nails are underutilized as diagnostic tools, despite being involved in many dermatologic conditions. This paper explores new concepts in the treatment of median nail dystrophy (MND), onychomycosis, and the nail pathology of hand, foot, and mouth disease (HFMD). A Pubmed database literature search was conducted for MND treatment, onychomycosis treatment, and HFMD nail pathology. Only papers published after January 2008 were reviewed. The results showed that 0.1% tacrolimus ointment can be an effective treatment for MND. Early studies on laser therapy indicate that it is a safe and efficacious treatment option for onychomycosis, compared to conventional oral antifungal agents. Vicks VapoRub (The Proctor & Gamble Company, Cincinnati, OH) is effective against onychomycosis and is a reasonable option in patients who choose to forgo conventional treatments. Lastly, there is evidence to support a correlation between HFMD and onychomadesis.


 

 Hand, Foot and Mouth Disease (HFMD) and onychomadesis


HFMD is usually caused by coxsackievirus A 16. Less commonly, it is caused by coxsackievirus A4, A5, A6, A7, A9, A10, A24, B2 to B5, enterovirus 71, and echoviruses.

All are RNA viruses and they spread by fecal-oral and respiratory routes. Spread to other family members commonly occurs.
HFMD is characterized by vesicular stomatitis and cutaneous lesions on the palms and soles. The disease has an incubation period of 3 to 6 days . There is usually a mild prodrome consisting of low-grade fever, anorexia, sore mouth, and malaise. Children younger than 10 years are most commonly affected. Oral lesions occur chiefly on the anterior buccal mucosa and tongue, where the vesicular surfaces are eroded rapidly, leaving ulcers with erythematous borders.

The lesions on the palms and soles are papules or vesicles on a surrounding zone of erythema. Less commonly, the dorsal or lateral surfaces of the hands and feet may also been affected. Involvement of the buttocks is common, but typically there is a lack of vesiculation.

The eruptions are nonpruritic and usually resolve without crusting. The association between HFMD and onychomadesis was first proposed by Clementz and Mancini in 2000 and Bernier et al. in 2001. Onychomadesis is the spontaneous separation of the nail plate from the matrix starting at the proximal edge and is the result of the temporary cessation of nail formation. Recently, authors in Spain and Finland have brought forth evidence to solidify the association between these conditions.
A study of an outbreak of HFMD in daycare centers and schools during the fall of 2008 in Finland led to one characteristic feature being found amongst the infected population: shedding of the nail plate approximately 1-2 months after the onset of classic HFMD symptoms. Redondo et al. documented a similar onychomadesis observation during an HFMD outbreak in Valencia, Spain in the winter of 2008. Fifteen children and one adult presented with nail changes consistent with onychomadesis, a mean of 6 weeks after the clinical diagnosis of HFMD. The nail changes were temporary with spontaneous normal regrowth in 1–4 months.

Clustered and sporadic HFMD cases, followed by onychomadesis (nail shedding), occurred during summer and fall 2008 in Valencia, Spain. Fecal samples from onychomadesis patients, who did or did not have previous HFMD, and from healthy children exposed to onychomadesis patients tested positive for EV.

The complete viral protein 1 capsid gene sequence was obtained for typing and phylogenetic analysis. Two EV serotypes, coxsackievirus A10 and coxsackievirus B1 (CVB1), were mainly detected as a monoinfection or co-infection in a childcare center where an onychomadesis outbreak occurred. On the basis of our results, and detection of CVB1 in 2 other contemporary onychomadesis outbreaks in childcare centers in Spain, we propose that mixed infection of an EV serotype that causes HFMD, plus the serotype CVB1, could explain the emergence after HFMD of onychomadesis, a rare and late complication.


Source:
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3302018/
http://wwwnc.cdc.gov/eid/article/17/12/11-0395_article.htm

Comments

Post a Comment

Popular posts from this blog

Reasons Why Your Hips Hurt

Hips Don't lie Inside the Joint Each hip is a ball-and-socket joint. The ball is the top of your thighbone (femoral head). The socket (acetabulum) is in your pelvic bone. Smooth, slippery tissue called cartilage lets the ball and socket glide against each other when you move. A thin lining (synovium) tops the cartilage and makes a bit of synovial fluid, which further eases rubbing.  Tendons, ligaments, and muscles complete the joint. Osteoarthritis It’s the “wear and tear” type of arthritis that many people get in middle age. Cartilage on the ball end of the thighbone and in the hip socket slowly breaks down and causes grinding between bones. You’ll have stiffness, and you might feel pain in your crotch and at the front of your thigh that radiates to your knee and behind. It’s often worse after a hard workout or when you don’t move for a while. Rheumatoid Arthritis With RA, your immune system attacks parts of your body, which can include the syn...
Post a Comment
Read more

Anesthesia Before Age 2 Linked to Learning Problems

There are new concerns about an increased risk for learning problems in very young children exposed to general anesthesia during surgical procedures. Researchers from the Mayo Clinic in Rochester, Minn., found a twofold increase in learning disabilities in children who had more than one exposure to general anesthesia with surgery before age 2. The study is published in the November issue of Pediatrics. The FDA requested and funded the study. Last spring, an FDA panel met to review the research examining the effect of early exposure to anesthesia on the developing brain. Following the meeting, FDA director of anesthesia and analgesia products Bob Rappaport, MD, wrote that additional studies are needed. He noted that "at present, there is not enough information to draw any firm conclusions" about the long-term impact of early exposure to general anesthesia on the brain. The new study adds to the evidence linking repeated exposure to general anesthesia very early i...
Post a Comment
Read more

FDA: 5 Death Reports for Monster Energy Drink

  The FDA is investigating reports of five deaths and a nonfatal heart attack in people who drank high- caffeine energy drinks made by the Monster Energy Company. Meanwhile, a Maryland couple has filed a wrongful death suit against the company, alleging that their product killed their 14-year-old daughter. They say Anais Fournier, 14, collapsed after drinking her second 24-ounce Monster Energy drink in two days. She died six days later. The reports are not proof that the drinks caused the deaths, but merely signal there might be a problem. Even if the deaths are determined to be caused by caffeine poisoning, the FDA will consider all sources of caffeine before blaming the deaths on the energy drink. In addition to caffeine, energy drinks contain other stimulants, including taurine and guarana , a caffeine-containing plant. Because energy drinks are sold as nutritional supplements, they are not regula...
Post a Comment
Read more